The Reduced Expression of EOLA1 May Be Related to Refractory Diabetic Foot Ulcer

Table 1

Demographics and laboratory results of diabetic foot patient cohorts.

Patients ()	Acute wound	Chronic wound	or value	value
	38	41
Female/male	8/30	12/29	0.70	0.40^#
Age (years)			-1.26	0.21
Wagner 2 (/%)	15/39.47	9/21.95
(/%)	23/60.53	32/78.05	2.86	0.09^#
Average hospitalization time (days)			-2.17	0.03
Surgical treatment ()	15/39.47	19/46.34	0.38	0.54^#
Debridement	2	3
Polymethylmethacrylate	4	2
Digital or ray amputation	9	11
Transtibial amputation	0	3
Vascular diseases (/%)	26/68.42	33/80.49	1.52	0.22^#
Neuropathy (/%)	28/73.68	33/80.49	0.52	0.47^#
Retinopathy (/%)	10/26.32	10/24.39	0.04	0.84^#
Nephropathy (/%)	17/44.74	9/21.95	4.63	0.03^#
Positive culture (/%)	30/78.95	31/75.61	0.13	0.72^#
Gram-negative bacteria (/%)	13/34.21	21/51.22
Gram-positive bacteria (/%)	17/54.84	10/24.39	3.81	0.15^#
(/%)	11/28.95	17/41.46
(/%)	27/71.05	24/58.54	1.35	0.25^#
HsCRP			0.25	0.80
PCT	1.14±2.66	0.12±0.16	1.48	0.16
IL-6			0.04	0.97
White blood cells, WBC (10^9/L)			-0.54	0.59
Neutrophil percentage (%)			0.41	0.68
Albumin (g/L)			0.19	0.85
Hemoglobin (g/L)			1.41	0.16
Ankle-brachial index, ABI			2.56	0.28^#
0.9-0.99 (critical value)	9	6
1.0-1.29 (normal range)	26	34
>1.3 (arteriosteogenesis)	3	1

^# test. -test was applied to all other parameters.